Literature DB >> 8051727

A new method for cytodestruction of bladder epithelium using protamine sulfate and urea.

S D Niku1, P C Stein, H C Scherz, C L Parsons.   

Abstract

Bladder epithelium relies primarily on the presence of a surface glycosaminoglycan (GAG) layer and the structural integrity of cell-cell contact to maintain impermeability to toxic urinary wastes. Previous clinical studies evaluating bladder permeability characteristics in interstitial cystitis patients had indicated that epithelial desquamation occurs after treatment with protamine sulfate (PS) followed by hypertonic urea. The following study was performed using rabbits to further investigate this finding. The urinary bladder was evaluated for optimal treatment conditions for epithelial removal. Protamine sulfate (1 to 10 mg./ml.) and urea (100 to 200 gm./ml.) were instilled into the bladder at volumes ranging from 5 to 60 ml. to that required for near maximum distention. After incubation at room temperature for 15 minutes, the bladders were fixed and evaluated histologically for epithelial removal. The maximum epithelial removal occurred when the bladders were distended, and when PS concentration was 5 to 10 mg./ml. and urea at 200 gm./l. There was greater epithelium removal after repeated treatments. Epithelial cells that were removed were not viable based on Trypan blue staining. There was no significant increase of C14 labeled urea in the plasma after 15 minutes. Rabbits that were followed for 6 weeks after treatment did not show any histological evidence of increased collagen deposition and/or fibrosis. This procedure may have important clinical value since it may remove sufficient bladder epithelium in patients with transitional cell carcinoma to have therapeutic benefit. This offers a realistic option for selective, nontoxic destruction of bladder epithelium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051727     DOI: 10.1016/s0022-5347(17)32648-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Interstitial cystitis: the painful bladder syndrome.

Authors:  R Doggweiler-Wiygul; J Blankenship; S A MacDiarmid
Journal:  Curr Rev Pain       Date:  2000

2.  Imidazolium salts as small-molecule urinary bladder exfoliants in a murine model.

Authors:  Patrick O Wagers; Kristin M Tiemann; Kerri L Shelton; William G Kofron; Matthew J Panzner; Karen L Wooley; Wiley J Youngs; David A Hunstad
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

3.  The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy.

Authors:  Matthew O Fraser; John P Lavelle; Michael S Sacks; Michael B Chancellor
Journal:  Rev Urol       Date:  2002

4.  Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model.

Authors:  Rheal A Towner; Nataliya Smith; Debra Saunders; Samuel B Van Gordon; Amy B Wisniewski; Karl R Tyler; Beverley Greenwood-Van Meerveld; Robert E Hurst
Journal:  J Urol       Date:  2014-11-14       Impact factor: 7.450

5.  A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis.

Authors:  M Cervigni; F Natale; L Nasta; A Padoa; R Lo Voi; D Porru
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-03-13

6.  A model for the function of glycosaminoglycans in the urinary tract.

Authors:  C L Parsons
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

7.  Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.

Authors:  Maia Terashvili; Bhavana Talluri; Watchareepohn Palangmonthip; Kenneth A Iczkowski; Patrick Sanvanson; Bidyut K Medda; Banani Banerjee; Christopher W Cunningham; Jyoti N Sengupta
Journal:  Neuropharmacology       Date:  2021-07-10       Impact factor: 5.273

Review 8.  BoNT/A in the Urinary Bladder-More to the Story than Silencing of Cholinergic Nerves.

Authors:  Hodan Ibrahim; Jacquie Maignel; Fraser Hornby; Donna Daly; Matthew Beard
Journal:  Toxins (Basel)       Date:  2022-01-12       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.